Tension-Type Headache
Investigational use for chronic tension-type headache; no study for this headache type was identified, and the proposed mechanism (muscle tension, venous congestion) is untested.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for tension-type headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for tension headache is investigational.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy designed for tension-type headache was identified in the literature searches. The only related data are one small uncontrolled Russian series of 10 women with high blood pressure, whose tension-type headache scores fell after treatment, and a few reports in other headache types. A previously cited case series could not be verified and was removed. There are no randomized controlled trials. Headache trials are highly susceptible to placebo response. First-line treatments — tricyclics (amitriptyline), behavioral therapy, postural and ergonomic correction, biofeedback, physiotherapy — remain standard of care.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after leech detachment
- Bruising and tenderness over the trapezius, occiput, and temples for 3 to 7 days
- Itching and irritation at bite sites for days to weeks
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of headache or neck pain for 1 to 2 days
- Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
- Delay of amitriptyline trial, CBT, biofeedback, and exercise - all with RCT support
- Placebo response masking medication-overuse headache or secondary causes
- Who should not consider this
- Patients taking blood thinners (warfarin, apixaban, rivaroxaban, dabigatran, heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with anemia
- Patients with a weakened immune system
- Patients with active medication-overuse headache (taper analgesics first)
- Patients with secondary headache (rule out structural/infectious cause first)
- Patients with red-flag headache features (sudden onset, neurological deficits, fever, immunosuppression, cancer history, age over 50 new-onset)
- Patients who have not tried amitriptyline (or alternative) at adequate dose and duration
- Patients with untreated depression or anxiety driving the headache
- Patients with active dermatitis or broken skin at planned placement sites
- What to ask your clinician
- Have I had medication-overuse headache and secondary causes ruled out?
- Have I completed an adequate trial of amitriptyline, physical therapy, biofeedback, and ergonomic correction?
- What evidence supports leech therapy for tension headache specifically?
- What is the practitioner's experience and Aeromonas-prevention plan?
- What is the realistic chance of benefit, given the tiny published evidence base?
- What is the cost, and what does it commit me to?
- Have we excluded migraine, cluster headache, cervicogenic headache, and medication-overuse headache?
- When to seek urgent care
- New or progressive neurologic symptoms — weakness, numbness, speech difficulty, vision change
- Sudden worst headache of life (call 911)
- Headache with fever, neck stiffness, or confusion
- Bleeding from bite sites lasting more than 24 to 48 hours
- Spreading redness, warmth, pus, or red streaks at bite sites
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
- Jaw claudication, scalp tenderness, or vision change in age over 50 (possible giant cell arteritis)
- New-onset headache during pregnancy or postpartum
What this does NOT mean
- This is not FDA-cleared for tension-type headache.
- Uncontrolled case reports or series are not evidence of efficacy in the general population.
- Mechanism rationale (muscle decongestion, anti-inflammatory peptides) does NOT establish clinical efficacy.
- Leech therapy does not address underlying drivers (medication overuse, postural, psychological).
- Reported benefit in a small series does not predict your individual response.
- It does not replace evidence-based prevention with RCT support.
Safety cross-references
Clinical Profile
- Category
- Neurological
- ICD-10
- G44.209, G44.219, G44.229
- Safety tier
- Low
Evidence Summary
No controlled trial and no study of leech therapy designed for tension-type headache was identified in PubMed, Europe PMC, ClinicalTrials.gov or Russian- and German-language searches. The only clinical data found are indirect: a Russian before-and-after series of 10 women with grade 1-2 hypertension, all with tension-type headache by questionnaire, reported lower headache scores after leech therapy (Chufarovskaya 2011; uncontrolled, with antihypertensive doses being reduced at the same time). Reports in other headache types are limited to a 7-patient migraine case series (Ansari 2019) and a single cluster-headache case report (Bhat 2024). A proposed mechanism (reduction of pericranial muscle tension via local anti-inflammatory salivary peptides plus venous decongestion) is untested. The evidence base is insufficient to recommend leech therapy over conventional management (tricyclics, biofeedback, physiotherapy); medication-overuse headache should be excluded before any adjunctive use is considered, and use remains investigational.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Medication-overuse headache (taper analgesics first)
- Cervical instability or vertebrobasilar insufficiency
Related Conditions
Migraine
Investigational use; the only clinical studies found in journal searches are a 7-patient case series and a 26-patient non-randomized pilot (older reports are described in “What the books describe”), and the proposed mechanism is hypothetical.
Chronic Rhinosinusitis
Investigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.
Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Lumbar Radiculopathy (Sciatica)
Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.